Ensysce Biosciences, Inc. (NASDAQ: ENSC) is a clinical-stage biotech company developing a new class of prescription drugs that will provide patients and prescribers safer options for the use of potent prescription drugs, reducing abuse and preventing overdoses.
View Top Employees from Ensysce BiosciencesWebsite | https://www.ensysce.com |
Ticker | ENSC |
Revenue | $7 million |
Funding | $60 million |
Employees | 11 (6 on RocketReach) |
Founded | 2008 |
Address | 7946 Ivanhoe Ave Suite 201, La Jolla, California 92093, US |
Phone | (858) 263-4196 |
Fax | (713) 790-0080 |
Technologies |
JavaScript,
HTML,
Twitter
+14 more
(view full list)
|
Industry | Biotechnology Research, Business Services General, Biotechnology, Business Services, Science and Engineering, Delivery, Administrative Services, Health Care, Medical, Nanotechnology, Pharmaceutical |
SIC | SIC Code 873 Companies, SIC Code 87 Companies |
NAICS | NAICS Code 541714 Companies, NAICS Code 5417 Companies, NAICS Code 541 Companies, NAICS Code 54 Companies, NAICS Code 54171 Companies |
Looking for a particular Ensysce Biosciences employee's phone or email?
The Ensysce Biosciences annual revenue was $7 million in 2024.
Dave Humphrey is the CFO of Ensysce Biosciences.
6 people are employed at Ensysce Biosciences.
Ensysce Biosciences is based in La Jolla, California.
The NAICS codes for Ensysce Biosciences are [541714, 5417, 541, 54, 54171].
The SIC codes for Ensysce Biosciences are [873, 87].